Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.86 -0.02 (-0.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Long-Term Debt Issuances (2022 - 2023)

Updated

Rigel Pharmaceuticals (RIGL) recorded Long-Term Debt Issuances of $19.95 million in FY2023, up 2.1% from $19.54 million in FY2022.

Analysis

Rigel Pharmaceuticals (RIGL) Long-Term Debt Issuances (2022 - 2023) Analysis & Trends

Starting with FY2019, Rigel Pharmaceuticals' Long-Term Debt Issuances history includes 4 years.

  • Annual Long-Term Debt Issuances has a four-year compound annual growth rate of 19.5% (FY2019 to FY2023).
  • Per Business Quant data, RIGL's Long-Term Debt Issuances was $19.54 million in FY2022, $9.98 million in FY2020 (+1.9%) and $9.79 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Rigel Pharmaceuticals 904.99 Mn 370.88 Mn 70.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 19.95 Mn
Sep 30, 2022 9.60 Mn
Jun 30, 2022 -33,000.00
Mar 31, 2022 9.98 Mn
API Access

Rigel Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RIGL&period=max&api_key=YOUR_API_KEY